Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04055051 · ClinicalTrials.gov registry record
ATHN 11: Liver Transplantation Outcomes Study
A clinical trial, sponsored by American Thrombosis and Hemostasis Network.
- Completed
- Registry status
- 86
- Enrollment target
NCT04055051: Completed study, sponsored by American Thrombosis and Hemostasis Network.
NCT04055051 is a clinical trial that has completed, run by American Thrombosis and Hemostasis Network. The registered enrollment target is 86 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04055051 has completed, sponsored by American Thrombosis and Hemostasis Network.
- COMPLETED
- Registry status
- 86 participants
- Enrollment target
Study Summary
This study is designed as a multi-center, observational cohort study of participants with hemophilia A and B who have and have not undergone liver transplantation. Participants will be asked to complete health related quality of life questionnaires and provide medical history.
Primary Outcome
Health related quality of life questionnaire Hemophilia Quality of Life Questionnaire for Adults (Haem-A-QoL): Domains include physical health, feelings, view of self, sports and leisure, work and school, dealing with hemophilia, treatment, future, family planning, and partnership and sexuality. For comparing questionnaire scores between two cohorts, we could use a combined score of PROMIS-29, Haem-A-QoL, and HOT questionnaires rescaled in 0-100 or use each separate survey.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2020-06-18 |
| Est. Completion | 2022-12-01 |
What the finished NCT04055051 record still lists
NCT04055051 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 86 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04055051 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04055051 about?
NCT04055051 is a clinical study titled "ATHN 11: Liver Transplantation Outcomes Study". This study is designed as a multi-center, observational cohort study of participants with hemophilia A and B who have and have not undergone liver transplantation. Participants will be asked to complete health related quality of life questionnaires and provide medical history.
What is the current status of trial NCT04055051?
This trial is currently completed. The enrollment target is 86 participants. The study started on 2020-06-18. Estimated completion is 2022-12-01.
Who is sponsoring clinical trial NCT04055051?
This trial is sponsored by American Thrombosis and Hemostasis Network, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI